and figure about 38 percent gross margin?
now with the news that nobody is interested, it confirms that there is little faith in their drug pipeline. the stock is way way ahead of itself. at least the market knows where things stand for this company and the stock. we should see a gradual decline in stock price from here. short at will.
no drug company is will to do so. this price is way too big of a gamble.
as i expected, these lowly pathetic koreans are releasing a gold color phone too. they just keep following and copying ideas from apple again and again. that inferior race...
he tells people to sell at 20, that is aflter almost 1/3 market cap lost from the high of near 30. he didn't tell people to sell just a week ago...only after the stock got sold off...wow. he must be really smart. anybody can be as smart as this guy to buy high and sell low, according to this guy.
i can't believe how people on tv tell people to buy near the high and sell near the low.
nothing has changed about this company's drug prospects. only the market making the price correction to the shares. if they were willing to pay 29 then, why wouldn't i consider paying a third less with all signs pointing to fda giving a favorable outcome? the fda was positive enough to tell the company the data was sufficient and they want the drug to hit the market asap.